Page last updated: 2024-11-01

niflumic acid and Nasopharyngeal Neoplasms

niflumic acid has been researched along with Nasopharyngeal Neoplasms in 1 studies

Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.

Research Excerpts

ExcerptRelevanceReference
"Niflumic acid (NFA) was known to inhibit cell proliferation or migration in several types of cancer."5.42Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9. ( Chen, C; Chen, H; Chen, L; He, Z; Huang, G; Huang, Z; Li, B; Li, H; Liao, D; Luo, S; Wan, Z; Wang, Z, 2015)
"Niflumic acid (NFA) was known to inhibit cell proliferation or migration in several types of cancer."1.42Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9. ( Chen, C; Chen, H; Chen, L; He, Z; Huang, G; Huang, Z; Li, B; Li, H; Liao, D; Luo, S; Wan, Z; Wang, Z, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luo, S1
Huang, G1
Wang, Z1
Wan, Z1
Chen, H1
Liao, D1
Chen, C1
Li, H1
Li, B1
Chen, L1
Huang, Z1
He, Z1

Other Studies

1 other study available for niflumic acid and Nasopharyngeal Neoplasms

ArticleYear
Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Division; Cell Line, Tumor; Cell Movement; Cell Pr

2015